0001387131-22-007441.txt : 20220701 0001387131-22-007441.hdr.sgml : 20220701 20220701160523 ACCESSION NUMBER: 0001387131-22-007441 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220629 FILED AS OF DATE: 20220701 DATE AS OF CHANGE: 20220701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEDERMAN SETH CENTRAL INDEX KEY: 0001563420 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36019 FILM NUMBER: 221061370 MAIL ADDRESS: STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP STREET 2: 509 MADISON AVE., SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp. CENTRAL INDEX KEY: 0001430306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261434750 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 MAIN STREET, SUITE 101 CITY: CHATHAM STATE: NJ ZIP: 07928 BUSINESS PHONE: 212-980-9155 MAIL ADDRESS: STREET 1: 26 MAIN STREET, SUITE 101 CITY: CHATHAM STATE: NJ ZIP: 07928 FORMER COMPANY: FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC. DATE OF NAME CHANGE: 20080320 4 1 lederman-form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP X0306 4 2022-06-29 0 0001430306 Tonix Pharmaceuticals Holding Corp. TNXP 0001563420 LEDERMAN SETH C/O TONIX PHARMACEUTICALS HOLDING CORP 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 1 1 0 0 Chief Executive Officer Common Stock, $0.001 par value 2022-06-29 4 P 0 20000 1.71 A 24235 I By IRA Account Common Stock, $0.001 par value 3505 D Common Stock, $0.001 par value 1 I By spouse Common Stock, $0.001 par value 1 I By Leder Laboratories, Inc. Common Stock, $0.001 par value 1 I By Starling Pharmaceuticals, Inc. Common Stock, $0.001 par value 7 I By Lederman & Co., LLC Common Stock, $0.001 par value 2 I By L&L Technologies, LLC Common Stock, $0.001 par value 2 I By Targent Pharmaceuticals, LLC Shares reported reflect a 1-for-32 reverse stock split effective May 17, 2022. Reporting person may be deemed to be a control person of this entity. /s/ Seth Lederman 2022-07-01